PORTAGE BIOMED LLC

Portage BioMed is a biotechnology research company developing novel and proprietary drug delivery systems to be used with various drug therapies in the treatment of diseases. Their primary research is in creating innovative systems for the safer and more efficient distribution of existing chemotherapeutic agents in the treatment of cancer.

#SimilarOrganizations #More

PORTAGE BIOMED LLC

Industry:
Biotechnology Health Care

Address:
Kent, Ohio, United States

Country:
United States

Status:
Active


Similar Organizations

ablexis-logo

Ablexis

Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.

novelmed-therapeutics-logo

NovelMed Therapeutics

NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.

tensixteen-bio-logo

TenSixteen Bio

TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.

More informations about "Portage BioMed LLC"

Portage BioMed LLC - Drug pipelines, Patents, Clinical trials

Explore Portage BioMed LLC with its drug pipeline, therapeutic area, technology platform, . Biomedical products. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for โ€ฆSee details»

Nutra Pharma acquires Portage BioMed LLC - Crunchbase

Nov 9, 2004 Portage BioMed LLC Portage BioMed LLC is a biotechnology research company developing novel and proprietary drug delivery systems. Acquiring Organization: Nutra โ€ฆSee details»

Portage BioMed LLC - Crunchbase

Portage BioMed LLC is a biotechnology research company developing novel and proprietary drug delivery systems.See details»

Portage BioMed LLC - Company Profile and News - Bloomberg โ€ฆ

Company profile page for Portage BioMed LLC including stock price, company news, executives, board members, and contact informationSee details»

Portage BioMed LLC Company Profile, Financial and Strategic

Portage BioMed, LLC provides biotechnology research services. The company develops drug delivery systems that are used with drug therapies in the treatment of cancer and other โ€ฆSee details»

Portage Biotech - Company Profile - Tracxn

Oct 21, 2024 Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs and โ€ฆSee details»

Home - Portage Biotech

Portage Biotech (NASDAQ: PRTG) is a clinical-stage immuno-oncology company advancing first-in-class therapies that target known checkpoint resistance pathways to achieve durable โ€ฆSee details»

PORTAGE BIOMED - Ohio Company

PORTAGE BIOMED. PORTAGE BIOMED (Entity Number: 1472281) was incorporated on 06/21/2004 in Ohio. ... PORTAGE STREET RETAIL, LLC Active. PORTAGE FIREARMS โ€ฆSee details»

Corporate Presentation - Portage Biotech

Portageโ€™s iNKT Engager (PORT-2): Rationally Designed Liposomal Formulation of IMM60 iNKT in charged liposome to protect lipid chain, aggregate in tumor, and promote Type 1 cytokine โ€ฆSee details»

Portage Biotech Inc. | The Canadian Securities Exchange (CSE)

Oct 28, 2013 Portage Biotech Inc. Listing Date. October 28, 2013. Portage is a unique entity in the world of biotechnology, enabling research and development to produce more clinical โ€ฆSee details»

Nutra Pharma - Funding, Financials, Valuation & Investors

Nov 13, 2001 Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Portage BioMed LLC . Nov 9, โ€ฆSee details»

Portage Biotech Reports Fiscal Year-Ended March 31, 2023 โ€ฆ

Mar 31, 2023 About Portage Biotech Inc. Portage is a clinical-stage immuno-oncology company advancing multi-targeted therapies to extend survival and significantly improve the lives of โ€ฆSee details»

Portage Biotech Company Profile - Office Locations, Competitors โ€ฆ

Apr 12, 2021 Portage Biotech to Participate in Citi's 2023 Virtual Oncology Leadership Summit Feb 15, 2023 Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022See details»

Portage Biotech Creates A New Drug Development Model

Nov 21, 2022 Portage will also use that extended network to ensure it has a seasoned executive involved in every discipline required for drug development. By avoiding the large infrastructure โ€ฆSee details»

Portage Biotech Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Portage Biotech Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»

Portage Biotech Provides Research and Development Update

WESTPORT, Conn., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company developing therapies to improve patient โ€ฆSee details»

Portage Biotech - Crunchbase Company Profile & Funding

Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs. Following proof of โ€ฆSee details»

PORT-4 โ€“ Nanolipogel Formulations - Portage Biotech

Portage is creating proprietary DNA aptamers โ€“ short sequences of DNA specifically designed to bind to target receptors. These DNA aptamers are then packaged into nanolipogels (NLG), a โ€ฆSee details»

Portage Biotech - Funding, Financials, Valuation & Investors

Portage Biotech is a pharmaceutical company that identifies and develops best-in-class or first-in-class early-to-mid stage products. Search Crunchbase. ... How many investments has this โ€ฆSee details»

linkstock.net © 2022. All rights reserved